Cargando…

Microbiological, Histological, Immunological, and Toxin Response to Antibiotic Treatment in the Mouse Model of Mycobacterium ulcerans Disease

Mycobacterium ulcerans infection causes a neglected tropical disease known as Buruli ulcer that is now found in poor rural areas of West Africa in numbers that sometimes exceed those reported for another significant mycobacterial disease, leprosy, caused by M. leprae. Unique among mycobacterial dise...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sarfo, Fred Stephen, Converse, Paul J., Almeida, Deepak V., Zhang, Jihui, Robinson, Clive, Wansbrough-Jones, Mark, Grosset, Jacques H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597478/ https://www.ncbi.nlm.nih.gov/pubmed/23516649 http://dx.doi.org/10.1371/journal.pntd.0002101

Ejemplares similares

Kinetics of mycolactone in human subcutaneous tissue during antibiotic therapy for Mycobacterium ulcerans disease
por: Sarfo, Fred S, et al.
Publicado: (2014)

BCG-Mediated Protection against Mycobacterium ulcerans Infection in the Mouse
por: Converse, Paul J., et al.
Publicado: (2011)

Activities of Rifampin, Rifapentine and Clarithromycin Alone and in Combination against Mycobacterium ulcerans Disease in Mice
por: Almeida, Deepak, et al.
Publicado: (2011)

Accelerated Detection of Mycolactone Production and Response to Antibiotic Treatment in a Mouse Model of Mycobacterium ulcerans Disease
por: Converse, Paul J., et al.
Publicado: (2014)

Recent advances: role of mycolactone in the pathogenesis and monitoring of Mycobacterium ulcerans infection/Buruli ulcer disease
por: Sarfo, Fred Stephen, et al.
Publicado: (2015)

Bactericidal Activity Does Not Predict Sterilizing Activity: The Case of Rifapentine in the Murine Model of Mycobacterium ulcerans Disease
por: Almeida, Deepak V., et al.
Publicado: (2013)

Rapid, Serial, Non-invasive Assessment of Drug Efficacy in Mice with Autoluminescent Mycobacterium ulcerans Infection
por: Zhang, Tianyu, et al.
Publicado: (2013)

Detection of Mycolactone A/B in Mycobacterium ulcerans–Infected Human Tissue
por: Sarfo, Fred Stephen, et al.
Publicado: (2010)

Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease
por: Converse, Paul J., et al.
Publicado: (2015)

Genetic Diversity of PCR-Positive, Culture-Negative and Culture-Positive Mycobacterium ulcerans Isolated from Buruli Ulcer Patients in Ghana
por: Williamson, Heather, et al.
Publicado: (2014)

Shorter-course treatment for Mycobacterium ulcerans disease with high-dose rifamycins and clofazimine in a mouse model of Buruli ulcer
por: Converse, Paul J., et al.
Publicado: (2018)

Clearance of viable Mycobacterium ulcerans from Buruli ulcer lesions during antibiotic treatment as determined by combined 16S rRNA reverse transcriptase /IS 2404 qPCR assay
por: Sarpong-Duah, Mabel, et al.
Publicado: (2017)

Photodegradation of the Mycobacterium ulcerans Toxin, Mycolactones: Considerations for Handling and Storage
por: Marion, Estelle, et al.
Publicado: (2012)

Regulation of Mycolactone, the Mycobacterium ulcerans Toxin, Depends on Nutrient Source
por: Deshayes, Caroline, et al.
Publicado: (2013)

Membrane perturbing properties of toxin mycolactone from Mycobacterium ulcerans
por: López, Cesar A., et al.
Publicado: (2018)

Rapid detection of Mycobacterium ulcerans with isothermal recombinase polymerase amplification assay
por: Frimpong, Michael, et al.
Publicado: (2019)

Selective suppression of dendritic cell functions by Mycobacterium ulcerans toxin mycolactone
por: Coutanceau, Emmanuelle, et al.
Publicado: (2007)

Development of an ELISA for the quantification of mycolactone, the cytotoxic macrolide toxin of Mycobacterium ulcerans
por: Warryn, Louisa, et al.
Publicado: (2020)

IFN-γ and IL-5 whole blood response directed against mycolactone polyketide synthase domains in patients with Mycobacterium ulcerans infection
por: Loglo, Aloysius D., et al.
Publicado: (2018)

Clinical, Microbiological and Pathological Findings of Mycobacterium ulcerans Infection in Three Australian Possum Species
por: O'Brien, Carolyn R., et al.
Publicado: (2014)

Molecular Mechanisms Underpinning the Circulation and Cellular Uptake of Mycobacterium ulcerans Toxin Mycolactone
por: Tello Rubio, Bruno, et al.
Publicado: (2021)

Providing insight into the incubation period of Mycobacterium ulcerans disease: two case reports
por: Amoako, Y. A., et al.
Publicado: (2019)

Mycobacterium ulcerans Disease, Peru
por: Guerra, Humberto, et al.
Publicado: (2008)

Corticosteroid Use for Paradoxical Reactions during Antibiotic Treatment for Mycobacterium ulcerans
por: Friedman, N. Deborah, et al.
Publicado: (2012)

Mycobacterium Ulcerans Treatment – Can Antibiotic Duration Be Reduced in Selected Patients?
por: Cowan, Raquel, et al.
Publicado: (2015)

Mycobacterium ulcerans DNA Not Detected in Faecal Samples from Buruli Ulcer Patients: Results of a Pilot Study
por: Sarfo, Fred S., et al.
Publicado: (2011)

Responses to chemical cross-talk between the Mycobacterium ulcerans toxin, mycolactone, and Staphylococcus aureus
por: Dhungel, Laxmi, et al.
Publicado: (2021)

Ongoing Genome Reduction in Mycobacterium ulcerans
por: Rondini, Simona, et al.
Publicado: (2007)

Mycobacterium ulcerans Treatment Costs, Australia
por: Drummond, Christina, et al.
Publicado: (2004)

Profiling Mycobacterium ulcerans with hsp65
por: Leão, Sylvia Cardoso, et al.
Publicado: (2005)

Histopathologic Features of Mycobacterium ulcerans Infection
por: Guarner, Jeannette, et al.
Publicado: (2003)

Mycobacterium ulcerans mycolactones-fungi crosstalking
por: Hammoudi, Nassim, et al.
Publicado: (2019)

The changing epidemiology worldwide of Mycobacterium ulcerans
por: O'Brien, D. P., et al.
Publicado: (2018)

Translocating Mycobacterium ulcerans: An experimental model
por: Hammoudi, Nassim, et al.
Publicado: (2020)

Proteomic Analysis of the Action of the Mycobacterium ulcerans Toxin Mycolactone: Targeting Host Cells Cytoskeleton and Collagen
por: Gama, José B., et al.
Publicado: (2014)

Skin-specific antibodies neutralizing mycolactone toxin during the spontaneous healing of Mycobacterium ulcerans infection
por: Foulon, Mélanie, et al.
Publicado: (2020)

Mutation and Diversity of Diphtheria Toxin in Corynebacterium ulcerans
por: Otsuji, Ken, et al.
Publicado: (2019)

Simple, Rapid Mycobacterium ulcerans Disease Diagnosis from Clinical Samples by Fluorescence of Mycolactone on Thin Layer Chromatography
por: Wadagni, Anita, et al.
Publicado: (2015)

Mycobacterium ulcerans Disease with Unusual Sites Not to Be Ignored
por: Abdoulaye, Sangaré, et al.
Publicado: (2014)

Update on Medicinal Plants with Potency on Mycobacterium ulcerans
por: Tsouh Fokou, Patrick Valere, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1crbrh0mh3k3mbmc8diqi7ma11